Germany patent battle?


Anonymous

Guest
Anyone know whats going on with this Edwards/Medtronic patent battle? Does Edwards have a shot?

Expect Edwards Lifesciences' ($EW) aggressive and increasingly hardcore heart valve patent battle with Medtronic ($MDT) to get worse in the coming weeks. An industry analyst predicts a German court will issue an injunction preventing Medtronic from selling its CoreValve transcatheter aortic valve replacement (TAVR) in that country. And continued legal action is advancing in the U.S.

http://www.fiercemedicaldevices.com...onics-corevalve-sale/2013-06-10#ixzz2W7Uh7vE0
 
































if you bought at 63... then yes you have turned a profit. otherwise you got caught in the speculative trade.

If you aren't buying EW when it hits sub65 then you probably don't like to make money.

EW looking strong. speculation making stock price very volatile. Its still a fantastic long term investment as many of their technologies add value to the patient (beyond just adding cost.)

i believe they have innovative technologies in the pipeline which will move the stock price and have acquisition targets that will move the market cap.
 









Write your reply...